- Report
- March 2025
- 200 Pages
Global
From €3983EUR$4,490USD£3,458GBP
- Report
- August 2025
- 238 Pages
Global
From €4346EUR$4,900USD£3,774GBP
- Report
- October 2025
- 194 Pages
Global
From €3145EUR$3,545USD£2,730GBP
€3494EUR$3,939USD£3,034GBP
- Report
- October 2025
- 188 Pages
Global
From €5189EUR$5,850USD£4,505GBP
- Report
- April 2025
- 250 Pages
Global
From €3983EUR$4,490USD£3,458GBP
- Report
- July 2025
- 160 Pages
United States
From €4391EUR$4,950USD£3,812GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4391EUR$4,950USD£3,812GBP
- Report
- April 2024
- 132 Pages
Global
From €843EUR$950USD£732GBP

Peripheral Arterial Disease (PAD) is a cardiovascular condition characterized by a narrowing of the arteries that supply blood to the limbs. It is caused by a buildup of plaque in the arteries, which can lead to a decrease in blood flow and oxygen to the legs and feet. Symptoms of PAD include pain in the legs and feet, numbness, and a decrease in the ability to walk. PAD is a major cause of disability and can lead to serious complications such as stroke, heart attack, and amputation. Treatment for PAD includes lifestyle changes, medications, and surgery.
The PAD market is a subset of the larger cardiology market, which includes treatments for a variety of cardiovascular conditions. Companies in the PAD market include Abbott, Boston Scientific, Medtronic, and Johnson & Johnson. These companies offer a range of products and services, including diagnostic tests, medical devices, and pharmaceuticals. Show Less Read more